Phosphorylation of anticancer nucleoside analogs by human mitochondrial deoxyguanosine kinase

Biochemical Pharmacology

Volumn 56, Issue 8, 1998, Pages 1035-1040

  Zhu, Chaoyong ^a   Johansson, Magnus ^a   Permert, Johan ^a   Karlsson, Anna ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Deoxycytidine kinase; Deoxyguanosine kinase; Nucleoside analogs; Nucleoside phosphorylation; Purine metabolism; Pyrimidine metabolism

Indexed keywords

ADENOSINE TRIPHOSPHATE; CLADRIBINE; DEOXYADENOSINE; DEOXYCYTIDINE; DEOXYCYTIDINE KINASE; DEOXYGUANOSINE; DEOXYGUANOSINE KINASE; GEMCITABINE; GUANINE ARABINOSIDE; NUCLEOSIDE ANALOG; UNCLASSIFIED DRUG; URIDINE TRIPHOSPHATE;

ARTICLE; DRUG METABOLISM; ENZYME SPECIFICITY; HUMAN; HUMAN CELL; MICHAELIS MENTEN KINETICS; PHOSPHORYLATION; PRIORITY JOURNAL; PURINE METABOLISM;

ANTINEOPLASTIC AGENTS; ANTIRHEUMATIC AGENTS; CELL EXTRACTS; CLADRIBINE; DEOXYGUANOSINE; HELA CELLS; HUMANS; KINETICS; NUCLEOSIDES; ORGANOGOLD COMPOUNDS; PHOSPHORYLATION; PHOSPHOTRANSFERASES (ALCOHOL GROUP ACCEPTOR); RECOMBINANT PROTEINS; SUBSTRATE SPECIFICITY; TUMOR CELLS, CULTURED;

EID: 0032531671     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-2952(98)00150-6     Document Type: Article

References (20)

1. Johansson M., Karlsson A. Cloning and expression of human deoxyguanosine kinase cDNA. Proc Natl Acad Sci USA. 93:1996;7258-7262.
2. Arner E.S. On the phosphorylation of 2-chlorodeoxyadenosine (CdA) and its correlation with clinical response in leukemia treatment. Leuk Lymphoma. 21:1996;225-231.
3. Wang L., Karlsson A., Arner E.S., Eriksson S. Substrate specificity of mitochondrial 2′-deoxyguanosine kinase. Efficient phosphorylation of 2-chlorodeoxyadenosine. J Biol Chem. 268:1993;22847-22852.
4. Hui Y.F., Reitz J. Gemcitabine, a cytidine analogue active against solid tumors. Am J Health-Syst Pharm. 54:1997;162-170.
5. Johansson M., Karlsson A. Cloning of the cDNA and chromosome localization of the gene for human thymidine kinase 2. J Biol Chem. 272:1997;8454-8458.
6. Gandhi V., Mineishi S., Huang P., Yang Y., Chubb S., Chapman A.J., Nowak B.J., Hertel L.W., Plunkett W. Difluorodeoxyguanosine, cytotoxicity, metabolism, and actions on DNA synthesis in human leukemia cells. Sem Oncol. 22:(Suppl 11):1995;61-67.
7. Gandhi V., Mineishi S., Huang P., Chapman A.J., Yang Y., Chen F., Nowak B., Chubb S., Hertel L.W., Plunkett W. Cytotoxicity, metabolism, and mechanisms of action of 2′,2′-difluorodeoxyguanosine in Chinese hamster ovary cells. Cancer Res. 55:1995;1517-1524.
8. Arner E.S., Spasokoukotskaja T., Eriksson S. Selective assays for thymidine kinase 1 and 2 and deoxycytidine kinase and their activities in extracts from human cells and tissues. Biochem Biophys Res Commun. 188:1992;712-718.
9. Eriksson S., Kierdaszuk B., Munch-Petersen B., Öberg B., Johansson N.G. Comparison of the substrate specificities of human thymidine kinase 1 and 2 and deoxycytidine kinase toward antiviral and cytostatic nucleoside analogs. Biochem Biophys Res Commun. 176:1991;586-592.
10. Park I., Ives D.H. Properties of a highly purified mitochondrial deoxyguanosine kinase. Arch Biochem Biophys. 266:1988;51-60.
11. Chottiner E.G., Shewach D.S., Datta N.S., Ashcraft E., Gribbin D., Ginsburg D., Fox I.H., Mitchell B.S. Cloning and expression of human deoxycytidine kinase cDNA. Proc Natl Acad Sci USA. 88:1991;1531-1535.
12. Gower Wr Jr, Carr M.C., Ives D.H. Deoxyguanosine kinase, distinct molecular forms in mitochondria and cytosol. J Biol Chem. 254:1979;2180-2183.
13. Johansson M., Brismar S., Karlsson A. Human deoxycytidine kinase is located in the cell nucleus. Proc Natl Acad Sci USA. 94:1997;11941-11945.
14. Shewach D.S., Daddona P.E., Ashcraft E., Mitchell B.S. Metabolism and selective cytotoxicity of 9-β-D-arabinofuranosylguanine in human lymphoblasts. Cancer Res. 45:1985;1008-1014.
15. Johansson M., Karlsson A. Differences in kinetic properties of pure recombinant human and mouse deoxycytidine kinase. Biochem Pharmacol. 50:1995;163-168.
16. White J.C., Capizzi R.L. A critical role for uridine nucleotides in the regulation of deoxycytidine kinase and the concentration dependence of 1-β-D-arabinofuranosylcytosine phosphorylation in human leukemia cells. Cancer Res. 51:1991;2559-2565.
17. Chen C.-H., Cheng Y.-C. The role of cytoplasmic deoxycytidine kinase in the mitochondrial effects of the anti-human immunodeficiency virus compound, 2′,3′-dideoxycytidine. J Biol Chem. 267:1992;2856-2859.
18. Magnani M., Brandi G., Casabianca A., Fraternale A., Schiavano G.F., Rossi L., Chiarantini L. 2′,3′-Dideoxycytidine metabolism in a new drug-resistant cell line. Biochem J. 312:1995;115-123.
19. Lewis W., Levine E.S., Griniuviene B., Tankersley K.O., Colacino J.M., Sommadossi J.P., Watanabe K.A., Perrino F.W. Fialuridine and its metabolites inhibit DNA polymerase gamma at sites of multiple adjacent analog incorporation, decrease mtDNA abundance, and cause mitochondrial structural defects in cultured hepatoblasts. Proc Natl Acad Sci USA. 93:1996;3592-3597.
20. Manome Y., Wen P.Y., Dong Y., Tanaka T., Mitchell B.S., Kufe D.W., Fine H.A. Viral vector transduction of the human deoxycytidine kinase cDNA sensitizes glioma cells to the cytotoxic effects of cytosine arabinoside in vitro and in vivo. Nat Med. 2:1996;567-573.